Cargando…
Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice
Non-alcoholic fatty liver disease (NAFLD) incorporates steatosis, non-alcoholic steato-hepatitis (NASH) and liver cirrhosis, associating with diabetes and cardiovascular disease (CVD). TNF-related apoptosis-inducing ligand (TRAIL) is protective of CVD. We aimed to determine whether TRAIL protects ag...
Autores principales: | Cartland, Siân P., Harith, Hanis H., Genner, Scott W., Dang, Lei, Cogger, Victoria C., Vellozzi, Melissa, Di Bartolo, Belinda A., Thomas, Shane R., Adams, Leon A., Kavurma, Mary M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432513/ https://www.ncbi.nlm.nih.gov/pubmed/28507343 http://dx.doi.org/10.1038/s41598-017-01721-4 |
Ejemplares similares
-
TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKL
por: Di Bartolo, Belinda A., et al.
Publicado: (2013) -
Correction: TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKL
por: Di Bartolo, Belinda A., et al.
Publicado: (2013) -
HDL Improves Cholesterol and Glucose Homeostasis and Reduces Atherosclerosis in Diabetes-Associated Atherosclerosis
por: Di Bartolo, Belinda A., et al.
Publicado: (2021) -
Comparative Evaluation of TRAIL, FGF-2 and VEGF-A-Induced Angiogenesis In Vitro and In Vivo
por: Cartland, Siân P., et al.
Publicado: (2016) -
TRAIL signals, extracellular matrix and vessel remodelling
por: Patil, Manisha S, et al.
Publicado: (2020)